Loved to visit the other side of ⁦@Wikipedia⁩ ⁦@wmnl⁩ ! And I really learned to appreciate the effort contributors put into writing entries. Thx ⁦@andrawaag⁩ Sandra and Frans for moderating. Please pay forward and start contributing yourself!

Great keynote at WCOP2022 in Cape Town by Rada Savic on translational pharmacometrics in TBC drug development #WCOP2022 #pmx Great to be at an in-person event again!

PD-value 🙏all participating in the mini symposium celebrating our five years of pharmacometrics! Amazing showcase of innovation in the #biotech realm & new drugs to fight devastating diseases, e.g. Acute Kidney Injury, IgA Nephropathy and Leigh's. Up to the next anniversary!

I am excited to announce that PD-value sponsors the More Chi Martial arts team for the World Championship Kempo 2019 in Spain. We at PD-value are very proud of all our talents and wish them a great competition! pd-value.com/sponsoring-a-ma…

An infographic and short overview of a new way to do #PK-PD #modeling on multivariate markers in #pharmacology #metabolomics #phmx. See our paper at sciencedirect.com/science/ar… – at Woerden, Nederland

Modelers at work. I hope you don't recognize me! #PAGE2017 – at Budapest, Hungary

Kristin Karlsson on pharmacometrics reporting for regulatory review at #PAGE2017 – at Budapest, Hungary

Joe Standing presenting on pediatrics studies and pharmacodynamics at #PAGE2017 – at Budapest, Hungary

Indeed the still pretty linear one-compartment model limits the results. Also, this plot confirms LRT is less sensitive to bias

Novel #model for tumor mutation load correlates with #immunotherapy #melanoma clinical outcomes ncbi.nlm.nih.gov/pmc/article…